INTRODUCTION
Diabetes mellitus (DM) is chronic metabolic disorder characterized by hyperglycemia due to subnormal functioning of insulin.
1,2 Diabetic hyperglycemia if not properly regulated may lead to life threatening micro and macro vascular complications including retinopathy, neuropathy and nephropathy. 3, 4 Many herbal preparations specifically extracts of garlic (Allium Sativum Linn.), have been claimed useful in controlling glycemic status in Diabetes Mellitus (DM). [5] [6] [7] [8] [9] [10] The important sulfur compound of garlic oil, Diallyldisulphide (DADS), has been proved to be beneficial in DM. 11, 12 Though it is known DADS may enhance insulin action as well as may favor insulin half-life but the mechanism of DADS in regulating glucose metabolism in DM is obscure. 11, 13 Gluconeogenesis, a process of glucose production from non carbohydrate precursors, is normally very active in diabetes mellitus due to lowered insulin action as insulin is known to suppress tissue proteolysis as well as gluconeogenesis. Apart from lactate and glycerol, the gluconeogenic aminoacids like alanine, aspartate, glutamate along with their corresponding α-keto derivates, pyruvate, oxaloacetate, α-keto glutarate promotes gluconeogenesis. 14, 15 Diabetic conditions as the tissue proteolysis suppression action of insulin is minimum due to lowered action of insulin as observed in Type-2 DM. Hence more amino acids and their corresponding α-keto acids are channeled through gluconeogenic pathway inducing more glucose production resulting in gluconeogenesis induced hyperglycemia. There are no simpler methods, apart from tracer techniques, to assess gluconeogenic status in diabetes mellitus. A simple method to assess gluconeogenic precursors and gluconeogenic enzymes looks promising. Hence a study was undertaken to establish the role of DADS on gluconeogenesis in alloxan diabetic rat liver slices by estimating the liver tissue levels of total amino acids (TAA), total keto acids (TKA) and the action of glucose-6-phophatase in DADS exposed alloxan diabetic liver slices.
MATERIALS AND METHODS

Chemicals
Diallyldisulphide, Metformin and Alloxan monohydrate were obtained from Sigma Aldrich Chemicals (St. Louis, U.S.A.) and the remaining chemicals used were of analytical grade.
Experimental animals
Healthy male Wistar rats weighing 200 ± 50g body weight were randomly selected from animal house, Basaveshwara Medical College and Hospital, Chitradurga, India. Animals were maintained at standard laboratory conditions 12 hours day-night cycle at temperature of 22 ± 2 0 C. The experiments were conducted as per the guidelines of CPCSEA under the supervision of Institutional Animal Ethics Committee (BMCH/IAEC/04 Biochem/2015).
Animal groups
Wistar albino rats were categorized into four different groups; group I served as normal control. Group II, III and IV overnight fasted rats were administered with single intraperitoneal injection of freshly prepared Alloxan monohydrate 150 mg/kg body weight. The onset of diabetes was monitored 48 hours after Alloxan injection by using urine strips (Mission Urine strips) and the animals that tested positive for glucose for 3 consecutive days were considered as diabetic rats employed in the present study. Rats were maintained on rat diet and water ad libitum for 30 consecutive days. On 31 st day all the rats were sacrificed and procured liver tissues. Each liver tissue was cut into small slices, group I and group II liver tissues were suspended in cold phosphate buffer saline pH 7.4. Group III and group-IV liver tissues were separately incubated with Diallyldisulphide 4mg per gram liver tissues and Metformin 4mg per gram liver tissues for 60 minutes at 37 0 C 18, 19 . Post exposure effect on activity of glucose -6-phoshatase, total amino acids, total keto acids and transaminases were also estimated using standard protocol.
Estimation of total amino acids (TAA) and total ketoacids (TKA)
Pre-incubation study-Liver slice weighing 0.5 g from every rat in each group were separately taken in incubation tubes. To all the tubes 1 ml phosphate buffer saline (PBS) pH 7.4 was added, followed by 6.5 ml double distilled water (DDW) and 1.0 ml sodium Tungstate (10%) as well as 1.0 ml 2/3 N Sulfuric acid were added, mixed well. To the tubes containing liver slices of reference standard group, added 10 µl Metformin (4 mg/g liver) and to the treatment group, 10 µl of DADS (4 mg/g liver) 20, 21 were added. Tubes were allowed to stand at room temperature for 15 minutes for proteins to precipitate. After that the tubes were thoroughly homogenized using Remi homogenizer for 6 minutes and were later centrifuged at 3500 rpm for 8 minutes. The clear supernatant was used for estimation TAA and TKA. Total amino acids were estimated by the method of Folin 22 where amino acids upon reaction with β-naphthoquinone-4-sulphonate in alkaline media produces a brown colour complex. The intensity of which is measured in a spectrophotometer at 480 nm wavelength. Keto acids present in Tungstate filtrate treated with Dinitro phenyl hydrazine (DNPH) produces corresponding hydrazones which react with strong alkali to form red colour which is measured at 540 nm in spectrophotometer. These values were taken as pre-incubation levels of TAA and TKA. 22, 23 Post-incubation study: Liver slice weighing 0.5 g of every rat of each group were separately taken in incubation tubes. Added 1 ml phosphate buffer saline (PBS) pH 7.4 to all the test labeled tubes. Followed by 2 mg DADS as 10 µl normal saline solution to Group III and 2 mg of Metformin as 10 µl normal saline solution to Group IV test tubes respectively. The tubes were incubated for 60 minutes at 37 0 C in a thermostatically regulated water bath. After incubation 6.5 ml double distilled water, 1.0 mL of sodium Tungstate (10%) followed by 1.0 ml 2/3 N Sulfuric acid were added. The contents of the tubes were mixed well and were allowed to stand for 15 minutes for proteins to precipitate. Then the tubes were thoroughly homogenized using Remi homogenizer for 6 minutes and the clear supernatant was used for estimation of TAA 22 and TKA. 23 These values were considered as postincubation levels. These values were taken as pre-incubation levels of TAA and TKA. 22, 23 The differences between the post-incubation and pre-incubation values gives the total amount amino acid and keto acids produced during incubation period.
Estimation of glucose-6 phosphatase
Glucose-6 phosphatase was estimated by the phosphate release method.
24,25 0.5 g of liver tissue of each group was homogenized in 6 ml of double distilled water (DDW) and 0.1 ml of homogenate of each liver tissue of each group was separately incubated with 0.2 M glucose-6 phosphate in 0.1 M citrate buffer (pH6.3) for 30 minutes and the released inorganic phosphate was measured as explained originally by Fiske and Subbarow method. 25 
Estimation of transaminases (AST and ALT)
The same supernatant of post incubation studies were employed for estimation transaminases (AST and ALT) 26 levels were estimated by the colorimetric method of Reitman and Frankel separately in each liver homogenate of all the four groups.
Statistical analysis
Results were expressed as their Mean ± SEM. The statistical significance were assessed using Microsoft Excel 2007 (Redmond, Washington, USA) and SPSS package (Version16.0, IBM Corporation, New York, USA). The data were compared with diabetic control group using oneway ANOVA followed by Dunnett's multiple comparison test. P-values <0.05 were considered as statistically significant.
RESULTS
Single intraperitoneal injection of Alloxan readily induced diabetic in rats, which is confirmed from urine test. Biochemical investigations showed a significant increase in the total amino acids and total keto acids in diabetic control liver homogenate as compared to normal control (p<0.01). And there was significant increase in the glucose-6 phosphatase and transaminase (AST and ALT) activities as compared to normal control liver homogenate (p<0.01). Whereas the test drug DADS and Metformin significantly attenuated the raise in the total amino acids, total ketoacids and glucose-6 phosphatase and transaminase activities as compared to diabetic control. The DADS results were comparable with that of Metformin treatment (Tables 1  and 2 ).
It is evident from the figures that the ratios of TAA/TKA and (TAA+TKA)/(AST+ALT) are significantly elevated in diabetic control liver homogenate as compared to normal control, whereas DADS and Metformin incubation has shown significant reduction in the ratios as compared to diabetic control (p<0.01). The DADS results were comparable with that of Metformin treatment (Figures 1 and 2) . 
DISCUSSION
Gluconeogenesis, a pathway for the production of glucose from noncarbohydrate compounds, is one of the principle in vivo procedures for addition of glucose hence to maintain glucose homeostasis. The primary stimulus for gluconeogenesis may be lowered intra cellular glucose levels. It is known that insulin is the lone hormone suppressing gluconeogenesis and it acts predominantly by suppressing the expression of the genes for the key gluconeogenic enzymes involving glucose-6-phosphatase 27 and as the insulin action is sub normal in Type-2 DM, hence gluconeogenesis process becomes a significant for increased blood glucose levels leading to hyperglycemia. A simple procedure (non-tracer procedures) becomes essential in order to check gluconeogenesis induced hyperglycemia in DM.
In this study liver tissue levels of total amino acids, total keto acids and the activity of glucose-6 phosphatase have been assessed in DADS exposed alloxan diabetic liver slices (4 mg/g liver). The effects of DADS on these parameters were compared with Metformin, a standard anti diabetic drug by exposing alloxan diabetic liver slices to Metformin (4 mg/g liver). The results show a significant increase in TAA, TKA as well as Glucose-6-Phosphatase activity in diabetic control as compared to normal control. Establishing lowered insulin action in alloxan diabetic liver is responsible for the raise in TAA, TKA levels which are channeled through gluconeogenesis as there is a significant raise in activities of liver glucose-6-phosphatase. Whereas the TAA, TKA levels and glucose-6-Phosphatase activity are significantly lowered in DADS and Metformin treatment as compared to diabetic control. Indicating Metformin and DADS incubation has antiproteolytic as well as antigluconeogenic effects suggesting these compounds may control hepatic gluconeogenesis in alloxan diabetic rat liver. The ratios of liver TAA/TKA and liver TAA+TKA/ AST+ALT may be better marker for hepatic gluconeogenic rate in Alloxan diabetic rat, as they gives a rough estimation of utility of gluconeogenic precursors, amino acids and keto acids. Hence the level of these ratios becomes significant in assessing hepatic gluconeogenic status in Alloxan diabetic rats. The levels of these ratios are significantly elevated in diabetic control indicating increased flow of gluconeogenic precursors to gluconeogenesis. This is further evidenced by a significant fall in the levels of these ratios in DADS and Metformin treatment compared to diabetic control indicates that the DADS a comparable as well as a better anti-gluconeogenic effect in Alloxan diabetic liver.
It has been evident from earlier research that Metformin an antidiabetic drug, do regulate the hepatic gluconeogenesis by suppressing glucose-6 phosphatase action through a cyclic AMP mediated signaling transduction pathway involving cAMP-response element-binding protein (CBP/CREBP) signaling route. [28] [29] [30] It is evident from the present studies the glucose -6-Phosphatase levels are significantly lowered in DADS and Metformin suggesting DADS might have induced a reduction in hepatic gluconeogenesis similar to Metformin.
It is known that two closely situated cysteine residues in CBP are responsible for binding of CBP to DNA and further to initiate its action at this transcription level. 31, 32 DADS, is a low molecular wt. lipid soluble disulphide, similar to any other disulphide might have undergone a sulfhydryl reaction with these signaling molecules (CBP/CREB) and blocked its action, hence decreasing the formation of glucose-6-phosphatase thereby suppressing gluconeogenesis.
33,34
CONCLUSION
Based on the present study results we could say DADS can exhibit a significant decrease in hepatic gluconeogenesis by lowering flow of gluconeogenic amino acids and keto acids and this action is well comparable with Metformin the known anti diabetic drug suggesting DADS is a potent hepatic gluconeogenic modulator.
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